Clinical Trials in Tennessee

Showing 17941-17960 of 20,239 trials

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

NCT00092924

The purpose of this study is to evaluate the efficacy and safety of TRM-1 in subjects with relapsed or refractory non-small cell lung cancer.

Carcinoma, Non-Small-Cell Lung

Human Genome Sciences Inc.

Denver, Colorado, United States • Chicago, Illinois, United States • Durham, North Carolina, United States +2 more locations

COMPLETEDPhase 229 miles

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

NCT00094848

The purpose of this study is to evaluate the safety, efficacy and exposure to TRM-1 in subjects with relapsed or refractory Non-Hodgkin's Lymphoma (NHL).

Lymphoma, Non-Hodgkin

Human Genome Sciences Inc.Started Jun 2004

Rochester, Minnesota, United States • Omaha, Nebraska, United States • Buffalo, New York, United States +4 more locations

COMPLETEDPhase 229 miles

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

NCT00064051

RATIONALE: Drugs used in chemotherapy such as gemcitabine use different ways to stop tumor cells from dividing so they stop growing or die. 3-AP may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth and may help gemcitabine kill more cancer cells by making them more sensitive to the drug. PURPOSE: This phase II trial is studying how well giving gemcitabine together with 3-AP works in treating patients with unresectable or metastatic pancreatic cancer.

Pancreatic Cancer

Vion PharmaceuticalsStarted Jan 2003

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Minneapolis, Minnesota, United States +4 more locations

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Find Trials by Condition in Tennessee

Case-Control Viramune (Nevirapine) Toxicogenomics Study

Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders

Late-life Depression and Cerebral Perfusion

Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer

An Open Label Extension Study in Subjects With Fragile X Syndrome

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

Balloon REmodeling Antrostomy THErapy Study

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome

A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis

Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients

A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss